SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Zealand Pharma Announces New Results on Lixisenatide (Lyxumia(R)1) for Type 2 Diabetes Presented by Sanofi (France) at the 21st World Diabetes Congress